The pooled rate of Gal-3 positive results among carcinomas (i.e., Gal-3 sensitivity for thyroid malignancy histology) was 87% (95% CI from 86% to 88%), ranging from 53% to 100%. The gene discussed is LGALS3; the disease is carcinoma.